673 results on '"Bork K"'
Search Results
2. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting
3. Hereditary angioedema with a mutation in the plasminogen gene
4. Unerwünschte Arzneimittelwirkungen von Valproinsäure an der Haut und den hautnahen Schleimhäuten
5. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
6. Treatment for hereditary angioedema with normal C1‐INH and specific mutations in the F12 gene (HAE‐FXII)
7. Unerwünschte Arzneimittelreaktionen, Pathogenese, Klinik, Therapie
8. WAO/EAACI 遺伝性血管性浮腫治療ガイドライン―2021 年改定版.
9. WAO/EAACI.
10. Mutation Analysis in Hereditary Angioedema Identifies Patients at Risk for Developing Acute and Life Threatening Edema
11. Mutation Analysis of the C1 Inhibitor Gene
12. Caractéristiques anthropométriques et facteurs de risque cardio-métaboliques en milieu urbain au Sénégal: Anthropometric characteristics and cardiometabolic risk factors in urban-dwelling adults in Senegal
13. Anthropometric characteristics and cardiometabolic risk factors in a sample of urban-dwelling adults in Senegal
14. Organotypical Construction of a Hybrid Artificial Liver
15. Erkrankungen der Lippen und der Mundhöhle
16. Hereditäres Angioödem durch C1-Inhibitor-Mangel 1 1Bei diesem Beitrag handelt es sich um einen genehmigten Nachdruck des Springer Verlags. Veröffentlicht unter: Bork K et al. Hereditäres Angioödem durch C1-Inhibitor-Mangel. Allergo J, 2012; 21 (2): 109–118.
17. Unerwünschte Arzneimittelwirkungen von Valproinsäure an der Haut und den hautnahen Schleimhäuten
18. Urtikaria und Angioödem
19. Leberzelladenome nach Langzeitprophylaxe mit Danazol bei drei Patienten mit hereditärem Angioödem
20. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations
21. Uncommon Signs Associated With Hereditary Angioedema With Normal C1 Inhibitor
22. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
23. Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice
24. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema
25. Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor
26. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
27. A germline mutation in the platelet‐derived growth factor receptor beta gene may be implicated in hereditary progressive mucinous histiocytosis
28. Angioödem durch C1-Esterase-Inhibitor-Mangel oder ACE-Hemmer?
29. Hereditäre Angioödeme: S15/04
30. Autorenverzeichnis
31. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group
32. A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family
33. Generalisiertes bullöses fixes Arzneiexanthem (GBFDE) versus Stevens-Johnson-Syndrom (SJS) und Toxisch epidermale Nekrolyse (TEN): Unterschiede in Klinik, Ätiologie und Prognose: FV09/08
34. Wie behandle ich Patienten mit hereditärem Angioödem?: S08/08
35. Prophylaxis with C1 Inhibitor Concentrate before Tooth Extractions in Patients with Hereditary Angioedema: 1030
36. Definitive Link of Mutation c.351delC and Development of Hereditary Angioedema in a Large Brazilian Family: 381
37. Icatibant, a Selective Bradykinin-B2 Receptor Antagonist, in Acquired Angioedema Due to C1 Inhibitor Deficiency: 374
38. ALDEN, an Algorithm for Assessment of Drug Causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case-Control Analysis
39. Behandlung wiederholter Attacken eines hereditären Angioödems mit dem Bradykinin-B2-Rezeptorantagonisten Icatibant: FV09/05
40. Design & Evaluation of a Specific Algorithm for Drug Causality Assessment in Stevens-Johnson and Toxic Epidermal Necrolysis: 389.
41. Treatment of hereditary angioedema due to C1 inhibitor deficiency with Icatibant, a selective bradykinin B2 receptor antagonist: a safety perspective: 97
42. Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema
43. Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
44. Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
45. Erythema exsudativum multiforme majus und Stevens-Johnson-Syndrom: Unterschiede im klinischen Erscheinungsbild und in der Ätiologie: FV11/01
46. Aktuelle Therapie des hereditären Angioödems: S10/04
47. Drug-induced Angioedema: Co-factors and Course
48. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men
49. Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: Do prednicarbate and didecyldimethylammoniumchloride form a rational combination?
50. Pruritus precipitated by hydroxyethyl starch: a review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.